Tuesday, October 7, 2025

 

Novo joins Lilly in asking FDA for ban on GLP-1 …

5 days ago · Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and …

No comments: